This is my second Sera Prognostics (NASDAQ: SERA ) article, following 01/2024's "Sera Prognostics: The Pregnancy Company On A Hot Streak." In Hot Streak I rated Sera as a "Hold." Its hot streak has cooled noticeably, the company havingWriting under the pseudonym "out of ignorance", I very much regard investing as a learning process. Investing failures are tuition paid. Investing successes enter the trove of lessons learned. In my Seeking Alpha articles I share my experience from decades of investing and fro ...